Sunday, January 1, 2012

What Causes a Black Colored Tongue?

Patient Presentation
A 14-year-old caucasian male came to clinic because he had noticed his tongue becoming darker over the previous week. He was very concerned about the coloring as he said it would not go away. He was studying for school examinations and had been self-medicating an upset stomach with Pepto-Bismol®. About 1 month ago he was diagnosed with bronchitis at an urgent care center and had taken antibiotics. The past medical history was negative except for being overweight. The review of systems was negative. The pertinent physical exam showed a well-appearing male whose BMI was 28.9 with normal vital signs. HEENT showed poor oral hygiene with obvious caries. He had dark brown coloring of the top of the tongue anteriorly, not involving the sides, that was uniform. Scraping appeared to decrease the discoloration but it didn’t completely go away. There was no elevation of the tongue nor oral masses visible or palpable. There were some shoddy anterior cervical nodes. His neck had a normal thyroid examination and no masses. Skin examination showed acne on his face, and a few brown macules and freckles scattered on his trunk, arms and face that he reported to be unchanged. He had no discoloration of the palms or soles. The diagnosis of poor oral hygiene along with taking bismuth was made. He was counseled about the bismuth use and school stress. He was also counseled about oral hygiene including scraping of his tongue. Followup at 1 month showed that the discoloration had resolved and his stress after examinations.

Discussion
Although dental caries, strep throat and oral candidiasis are some of the most common oral pathology. The tongue itself can be a source of potential pathology. Geographic tongue, oral candidiasis, and lingual ulcerations are common problems. Most discolorations of the tongue are because of food, drink or medications that are ingested and are self-limited. However discoloration can be a sign of more significant problems.
Hairy tongue, often colored black, is a relatively uncommon problem in the US but has a higher incidence reported in Turkey and Iran. It is more common in adults than children but has been reported in a child 2 months of age. It is also called lingua villosa nigra and is a benign condition caused by keratin accumulation usually in the setting of poor oral hygiene and/or xerostomia. The accumulation is on the filliform papillae and will be seen on the dorsal surface anterior to the circumvallate papillae and not on the lateral sides of the tongue or tip. The discoloration can be different colors depending on the oral flora. Hairy tongue usually responds to oral hygiene including scraping of the tongue, but sometimes retinoids, keratolytic agents and other treatments are used.


Learning Point
The differential diagnosis of a black tongue includes:

Normal variation Poor oral hygiene Acanthosis nigracans Adrenal insufficiency Congenital lingual melanotic macules Congenital melanocytic naeviDrugs Antibiotics use Linzezold Minocycline Graft vs. Host Disease Heavy metals Infection Candida Kocuria (Micrococcus) kristinaeLingua villosa nigra “Black hairy tongue” Lupus (possibly associated) Neurofibromatosis Oncological Peutz Jegher Staining Bismuth Food coloring including coffee, tea Smoking

Questions for Further Discussion
1. What is the differential diagnosis of white lesions in the mouth?
2. What are the indications for referral for discoloration of the tongue and to whom would you refer?


Related Cases


To Learn More
To view pediatric review articles on this topic from the past year check PubMed.

Evidence-based medicine information on this topic can be found at SearchingPediatrics.com, the National Guideline Clearinghouse and the Cochrane Database of Systematic Reviews.


Information prescriptions for patients can be found at MedlinePlus for this topic: Tongue Disorders

To view current news articles on this topic check Google News.

To view images related to this topic check Google Images.

McGrath EE, Bardsley P, Basran G. Black hairy tongue: what is your call? CMAJ. 2008 Apr 22;178(9):1137-8.

Akl KF. Black tongue. J Paediatr Child Health. 2009 Jan-Feb;45(1-2):73-4.

Akay BN, Sanli H, Topcuoglu P, Zincircioglu G, Gurgan C, Heper AO. Black hairy tongue after allogeneic stem cell transplantation: an unrecognized cutaneous presentation of graft-versus-host disease. Transplant Proc. 2010 Dec;42(10):4603-7.

Thompson DF, Kessler TL. Drug-induced black hairy tongue. Pharmacotherapy. 2010 Jun;30(6):585-93.

Nisa L, Giger R. Black hairy tongue. Am J Med. 2011 Sep;124(9):816-7.

Oncel EK, Boyraz MS, Kara A. Black tongue associated with Kocuria (Micrococcus) kristinae bacteremia in a 4-month-old infant. Eur J Pediatr. 2011 Sep 21.

Guinovart RM, Carrascosa JM, Bielsa I, Rodriguez C, Ferrandiz C. A black tongue in a young woman. Clin Exp Dermatol. 2011 Jun;36(4):429-30.

ACGME Competencies Highlighted by Case

Patient Care
1. When interacting with patients and their families, the health care professional communicates effectively and demonstrates caring and respectful behaviors.
2. Essential and accurate information about the patients’ is gathered.
3. Informed decisions about diagnostic and therapeutic interventions based on patient information and preferences, up-to-date scientific evidence, and clinical judgment is made.
4. Patient management plans are developed and carried out.
5. Patients and their families are counseled and educated.
8. Health care services aimed at preventing health problems or maintaining health are provided. Medical Knowledge
10. An investigatory and analytic thinking approach to the clinical situation is demonstrated.
11. Basic and clinically supportive sciences appropriate to their discipline are known and applied. Interpersonal and Communication Skills
17. A therapeutic and ethically sound relationship with patients is created and sustained.
18. Using effective nonverbal, explanatory, questioning, and writing skills, the healthcare professional uses effective listening skills and elicits and provides information.
19. The health professional works effectively with others as a member or leader of a health care team or other professional group.

Author

Donna M. D’Alessandro, MD
Professor of Pediatrics, University of Iowa Children’s Hospital

This entry was posted on Monday, December 19th, 2011 at 12:29 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.


View the original article here

XOMA Initiates Gevokizumab Phase 2 Study for Moderate to Severe Acne Vulgaris

BERKELEY, Calif., Dec. 21, 2011 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) today announced it has begun dosing patients in its Phase 2 proof-of-concept study to evaluate the efficacy and safety of gevokizumab (XOMA 052), a potent inhibitor of interleukin-1 beta (IL-1 beta), for the treatment of the inflammatory lesions seen in moderate to severe acne vulgaris. Approximately 170 patients will be randomized to receive one of two dose levels of gevokizumab or placebo administered subcutaneously over a three-month period. The primary study efficacy endpoint is the mean absolute change from baseline in inflammatory facial lesion count after three months of therapy. Additional study information has been submitted for publication on www.clinicaltrials.gov

"XOMA's Phase 2 proof-of-concept program is designed to expand the value of gevokizumab, the company's lead clinical asset, by demonstrating its potential in diseases characterized by interleukin-1 beta over-expression. This is the first in a series of clinical studies that we plan to conduct in separate indications over the next 12 to 18 months," commented John Varian, Interim Chief Executive Officer of XOMA Ltd. "Upon completion of this series of proof-of-concept studies, we believe we will have sufficient evidence to initiate a further development program in at least one of these indications."

Moderate to severe acne vulgaris is estimated to affect approximately three to four million people in the U.S. Acne is characterized by the presence of a bacteria known as Proprionumbacterium acne, which promotes the production of proinflammatory substances including IL-1 beta in experimental models of the disease.

Moderate to severe acne that does not respond to topical agents is often treated with orally administered antibiotics. For the most severe, non-responsive acne, isotretinoin (an oral retinoid drug) treatment may be prescribed, although it is only available through a restricted distribution program due to its side effect profile.

About Gevokizumab and Interleukin-1 Inhibition

Gevokizumab (XOMA 052) is a potent monoclonal antibody with the potential to treat patients with a wide variety of inflammatory and other diseases. Gevokizumab binds strongly to interleukin-1 beta (IL-1 beta), a pro-inflammatory cytokine that has been shown to be involved in non-infectious uveitis including Behçet's uveitis, cardiovascular disease, and other auto-inflammatory diseases. By binding to IL-1 beta, gevokizumab inhibits the activation of the IL-1 receptor, thereby modulating the cellular signaling events that produce inflammation.

Gevokizumab has been studied in nearly 500 patients, with approximately 300 patients on treatment for six months, and has been shown to be well-tolerated. As previously reported, in a proof-of-concept Phase 2 trial of gevokizumab in Behçet's uveitis, all seven patients displayed rapid reduction of intraocular inflammation and improvement in visual acuity or other ophthalmic measures after a single treatment and following discontinuation of immunosuppressive drugs such as cyclosporine and/or azathioprine. Five of the patients were retreated with gevokizumab due to a recurring uveitis exacerbation and all responded again to treatment. Due to its ability to reduce C-reactive protein, gevokizumab also has potential for the treatment of cardiovascular and other inflammatory diseases.

About XOMA

XOMA is a leader in the discovery and development of novel antibody therapeutics. The company's proprietary product pipeline includes:

Gevokizumab (XOMA 052), a humanized antibody that binds to the inflammatory cytokine interleukin-1 beta, or IL-1 beta. XOMA plans to enter gevokizumab into Phase 3 clinical development in non-infectious uveitis affecting the intermediate and/or posterior segments of the eye, and has initiated a Phase 2 proof-of-concept trial for the treatment of moderate and severe acne vulgaris. Les Laboratoires Servier is XOMA's development and commercialization partner for gevokizumab. XOMA holds rights to gevokizumab in the U.S. and Japan for all non-cardiovascular and non-diabetes indications, including acne vulgaris, uveitis and Behçet's uveitis.Antibodies against botulinum toxins, led by XOMA 3AB, a novel combination of three antibodies to prevent and treat botulism poisoning caused by exposure to botulinum neurotoxin Type A, among the most deadly bioterror threats. XOMA 3AB is in a Phase 1 clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). Development of these antibodies has been funded in whole or in part with funds from NIAID, NIH, Department of Health and Human Services under Contract No. HHSN266200500004C, Contract No. HHSN266200600008C, Contract No. HHSN272200800028C, Contract No. HHSN266200600011C, Contract No., HHSN272200800026C, and Contract No. HHSN2722011031C.A preclinical pipeline with candidates in development for autoimmune, cardio-metabolic, inflammatory and oncological diseases. Among these are two new classes of fully human monoclonal antibodies that activate (XMetA) or sensitize (XMetS) the insulin receptor in vivo, which represent distinct new therapeutic approaches to the treatment of patients with diabetes.

XOMA has a premier antibody discovery and development platform that incorporates an unmatched collection of antibody phage display libraries and proprietary optimization and expression and manufacturing technologies that it uses for its own pipeline and in collaborations with pharmaceutical and biotechnology companies. XOMA's fully integrated product development infrastructure extends from preclinical science to approval and is located in Berkeley, California. For more information, please visit www.xoma.com.

The XOMA Ltd. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5960

Forward-Looking Statements

Certain statements contained herein concerning Phase 2 clinical trials or product development, or that otherwise relate to future periods are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on assumptions that may not prove accurate. Actual results could differ materially from those anticipated due to certain risks inherent in the biotechnology industry and for companies engaged in the development of new products in a regulated market.

Among other things, clinical trials may not be successful in achieving their goals, whether due to lack of efficacy or for safety, statistical or other reasons, and results of earlier-stage clinical trials may not be supported by results of later-stage trials.

These and other risks, including those related to the generally unstable nature of current economic and financial market conditions; the results of discovery and pre-clinical testing; the timing or results of pending and future clinical trials (including the design and progress of clinical trials; safety and efficacy of the products being tested; action, inaction or delay by the FDA, European or other regulators or their advisory bodies; and analysis or interpretation by, or submission to, these entities or others of scientific data); changes in the status of existing collaborative or licensing relationships; the ability of collaborators, licensees and other third parties to meet their obligations and their discretion in decision-making; XOMA's ability to meet the demands of the United States government agency with which it has entered into its government contracts; competition; market demand for products; scale-up, manufacturing and marketing capabilities; availability of additional licensing or collaboration opportunities; international operations; share price volatility; XOMA's financing needs and opportunities; uncertainties regarding the status of biotechnology patents; uncertainties as to the costs of protecting intellectual property; and risks associated with XOMA's status as a Bermuda company, are described in more detail in XOMA's most recent filing on Form 10-K and in other SEC filings. Consider such risks carefully when considering XOMA's prospects.

CONTACT: XOMA Ltd. Company and Investor Contact: Carol DeGuzman 510-204-7270 deguzman@xoma.com Canale Communications Media Contact: Pam Lord 619-849-6003 pam@canalecomm.com

Saturday, December 31, 2011

Acne and Skin Problem Myths Debunked

Isn't skin a wonderful thing to have?

An obvious benefit of skin is that it protects our bodies' internal organs from harmful elements like dirt, insects, bites, toxic chemicals, nasty weather, and the like, and it certainly is more attractive than what's underneath.

When skin is healthy it's nice to look at, but when it's diseased, it can not only affect you physically, but more painfully can cause stress and social problems.

Like the common cold, acne and similar skin diseases can be treated and covered up, but cannot really be cured. The best treatment is prevention and knowledge about what makes your skin happy, so that you can avoid skin care enemies and breakout triggers.

The real cause of acne can vary from individual to individual, but some factors can be stated with relative certainty:

1. Acne occurs when pores or hair follicles become blocked or clogged.

2. There are basically 4 types of acne manifestations: whiteheads, blackheads, pimples, and nodules.

3. Acne can appear pretty much anywhere on the skin, though it causes the most concern when it shows up on the face. The worst forms of acne break out, however, on the chest and back, and most commonly on males rather than females because of hormonal differences.

4. There are many common myths and untruths about acne, rosacea, and other skin care problems.

Some acne myths include "you'll outgrow it, so leave it alone", "being out in the sun helps acne", "acne problems are directly or indirectly proportionate to sexual activity", "acne visits dirty people", "acne is contagious", and too many more to list in this short article.

The sad thing is that belief in the myths can be devasting, in that proper treatment is avoided, and lifestyle changes that don't need to be made can take away pleasure unnecessarily.

For example, at one point in my life, I truly believed that I was allergic to chocolate and that it caused my breakouts. Whenever I would succumb to the temptation and have "just a little" I would stress out waiting for the red spots, and sure enough they would appear.

After several years and much experimentation, I learned I had no allergy, the stress was a trigger for me, and a new over the counter face scrub has kept me in the clear ever since.

Knowing what triggers your breakouts can be the difference between constant battles and healthy skin. The Internet is a wonderful place to get the information you need, so stop stressing out and learn what it takes to put your best face forward.

Friday, December 30, 2011

Acne Control The Natural Way!

Want to get rid of those zits in your face but you are currently low on budget? How about looking for acne control to avoid the sudden appearance of acne in your skin? So how do we do this?

First, what is acne? Acne is a skin disorder caused by the hormones action on the oil glands of the skin which is called the sebaceous glands. The excretion of oils from this glands can lead to congested skin pores. This is when acne occurs. The face, neck, chest, back and shoulders is where the glands are most profuse, that is why most acne are found on this locations. People who are with this kind of disorder often tends to be depressed, and humiliated.

There are a lot of factors that can generate acne to transpire. First is our Genes. Genetics can't be changed but other factors like our daily routine and the way we take care of our skin can be improved to make acne control no problem at all. Don't feel so sad about your acne because there's lots of things you can do. This acne control tips will help you say bye-bye to those zits.

1. Include Fruits and Vegetables in your daily Diet. A healthy diet consists of at least four to five servings of fruits and vegetables. Acne control will be a lot easier if you start including this in your daily habit.

2. Rose water can be used as a facial cleanser. Dipped in a cotton, clean your face using this everyday for at least two to three times each day.

3. Don't wait for your pimples to form. If you see a bit of it in your face, do something. Acne control is best done early. Pat some ice on the affected area for this will make it less swollen.

4. Acne control is easier when accompanied with multivitamins. Start taking vitamins that contains zinc supplement. Zinc helps in making your skin stronger and acne resistant.

5. Cucumber can help in acne control. Blend it with some water to form a mask. Put it in your face and leave it for about half an hour before rinsing it off. This is a good and affordable acne control remedy that can also refresh your skin.

6. Use only mild soaps and avoid soaps that contains petroleum based products and animal based ingredient for this causes your skin to get dry and irritated.

7. Using alcohol free facial cleansers makes Acne control trouble-free. Alcohol tends to dry your skin more.

8. Makeup also prompt the occurrence of acne. Choose your makeup wisely. Most of the makeup available contains petroleum based ingredients that makes skin dry. An all natural makeup helps acne control become more effortless.

9. Lastly, Drinking loads of water is very important. It flushes out the dirt in our body, Making acne control more natural.

Now you have a list of some helpful tips in acne control. It is your choice if you are to do these methods. There are lots of ways in acne control, be it naturally or by technology. Skin products are always around for you to pick your choice. The thing is, these products are very costly. If you are the innovative type of person, better try this methods in acne control. It is all natural and wont do any harm in your body. No side effects of course! Plus, you can really save a bunch out of this. There's no harm in trying! Saying goodbye to those acne is just a step away!

Acne DOs and DON'Ts

Every little thing counts when it comes to fighting acne and keeping it under control. After all, zits are not that big themselves, they just bug us in a big way. We don't always realize that seemingly insignificant things can help us look better (or worse, depending on what they are), while intentionally following myths, we do more harm than good to the skin.

Here are a few things to consider if you don't want to see those pimples pop up.

DO:

=> Clean your face twice a day. Use a cleanser that is designed for your skin type and avoid harsh and irritating products. When cleaning your skin and rinsing it with water (make sure to use plenty!), move from the neck to the hairline - that way you are not likely to spread hair build up over your face, as it can aggravate acne.

=> If you work out and sweat, clean your face after you exercise.

=> Use a moisturizer for your skin type. Even if your skin is oily, don't ignore this important part of your daily routine. Your skin needs protection. Overdrying your skin will not do any good: on the contrary, the oil glands will start working even harder.

=> Choose cosmetics made for your skin type.

=> Use products with fruit acids. They help to shed old skin cells and prevent pore clogging. You are not likely to see the results overnight, but be patient and stick to the treatment - you will be pleasantly surprised.

=> Protect your skin from wind and harsh environment as they make skin prone to infections.

=> Shampoo your hair regularly. Oil glands on your scalp produce the same sebum as those on your face. Add hair care products residues and environmental elements that stick to your hair - and you have a super-effective acne causing solution.

=> Drink lots of water to clean your body of toxins and keep your skin hydrated from the inside.

=> Take vitamins and eat a healthy diet. People who suffer from acne often don't get enough vitamin A in their diets (you may want to consult your doctor about that since large doses of vitamin A can be toxic). Zinc supplements are known to fight acne outbreaks. Healthy eating is good for all parts of your body. While diet changes alone won't spare you of acne, they will help your skin look better.

=> See a doctor if your acne is severe.

DON'T:

=> Don't use drying cleansers and harsh scrubs. They destroy the protective barrier and alter skin pH, making skin vulnerable and prone to infections. Astringents should be used on oily areas only.

=> Don't squeeze zits. This is the worst thing to do, and for many the hardest to avoid. Still, if you don't want to aggravate the condition, don't pick on your pimples. You can, however, drain them with a sterilized needle once they are mature.

=> Don't scratch or rub your skin. Sometimes rubbing can cause zits on otherwise clear complexion. You may want to experiment if you are brave enough, otherwise try to keep your hands off your face and avoid wearing hats, helmets or bands that may cause unpleasant surprises.

=> Don't tan. Even though tan will mask the blemishes, the effect is temporary. Excessive sun exposure can aggravate acne. Many over-the-counter and prescription acne products make your skin sensitive to sun. In addition to causing skin dehydration and premature aging, UV rays destroy cells responsible for skin's immunology